Twenty-six patients (9.12%) with tumor < 1 cm and without risk factor (lymph node involvement, extra-capsular invasion, unfavorable histological subtype, multifocal disease, or BRAF-positive) were not submitted to adjuvant radioiodine ablation. This evidence concerns the gene BRAF and neoplasm.